Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-03-27

Clinical Trial Update: Clinical Trial With Mesalamine 1g Suppositories [Phase 3]

View source ↗

Summary

A Phase 3 trial of mesalamine 1 g suppositories for proctitis has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mesalamine 1 g suppositories (mesalamine)

Snippet

Sponsor: Sandoz | Conditions: Proctitis | Phase 3 | Status: TERMINATED